NCT04334759: An ongoing trial by PrECOG, LLC.
This trial is ongoing. It must report results 6 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT04334759 |
|---|---|
| Title | DREAM3R: DuRvalumab (MEDI4736) With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma - A Phase 3 Randomised Trial |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Feb. 18, 2021 |
| Completion date | June 20, 2025 |
| Required reporting date | June 20, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |